Physician profile
Michael A German
NPI 1336398627
$2,333.16
in general payments reported to CMS, 2019-2025
21 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $158 · 2021: $189 · 2022: $378 · 2023: $401 · 2024: $541 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $847.38 | 2022-2025 | |
| Glaxosmithkline, LLC. | $523.61 | 2021-2025 | Nucala |
| Smith+Nephew, INC. | $137.05 | 2019-2025 | Stravix |
| Optinose US, INC. | $134.25 | 2019-2024 | |
| Kls-Martin L.P. | $128.97 | 2021-2024 | |
| Stryker Corporation | $109.71 | 2019-2024 | Clarifix Cryotherapy Device |
| Intersect Ent, INC. | $103.36 | 2019-2020 | |
| Amgen INC. | $40.18 | 2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $37.83 | 2024 | Dupixent |
| Merck Sharp & Dohme LLC | $33.49 | 2021-2023 | |
| Integra Lifesciences Corporation | $28.46 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Hospira, INC. | $27.40 | 2024 | |
| Osteomed LLC | $25.07 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.52 | 2021 | |
| Acclarent, INC | $23.39 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $23.33 | 2020 | |
| Lilly USA, LLC | $23.03 | 2022 | |
| Baxter Healthcare | $19.92 | 2025 | Tisseel |
| Zyla Life Sciences, INC. | $16.82 | 2020 | |
| Medtronic USA, INC. | $13.82 | 2020 | |
| Forte Bio-Pharma LLC | $12.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael German listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.